Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
264.00    0.50 (0.19%)
Bid:
263.00
Ask:
265.00
Spread: 2.00 (0.76%)
Market Cap: £351.51m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Holding(s) in Company

12 Dec 2014 16:02

RNS Number : 6937Z
Restore PLC
12 December 2014
 

 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

RESTORE PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other

3. Full name of person(s) subject to thenotification obligation: iii

HARGREAVE HALE LIMITED

4. Full name of shareholder(s)  (if different from 3.):iv

DISCRETIONARY CLIENTS

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

11 DECEMBER 2014

6. Date on which issuer notified:

12 DECEMBER 2014

7. Threshold(s) that is/are crossed orreached: vi, vii

14%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Indirect

Direct xi

Indirect xii

Direct

Indirect

GB00B5NR1S72

11,525,225

11,525,225

11,450,460

11,450,460

13.9277%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

11,450,460

13.9277%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

6,545,125 of these shares are held for unit trusts operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the portfolio of investments on a discretionary basis. The remaining balance is held on behalf of other discretionary clients.

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

David Clueit

15. Contact telephone number:

01253 754739

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLQKBDKABDDDBD
Date   Source Headline
13th Mar 202512:24 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSFull year 2024 results
13th Mar 20257:00 amRNSAcquisition of Synertec (Holdings) Ltd
4th Mar 20258:04 amRNSHolding(s) in Company
4th Feb 20259:23 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSNotice of full year results
21st Nov 20247:00 amRNSTrading Update
7th Nov 20247:00 amRNSNotice of Trading Update
31st Oct 20241:07 pmRNSHolding(s) in Company
24th Oct 20247:00 amRNSAnalyst and Investor Site Visit
22nd Oct 20242:26 pmRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSBoard Change
2nd Sep 20247:00 amRNSDirector/PDMR Shareholding
23rd Aug 20249:21 amRNSDirector/PDMR Shareholding
16th Aug 202410:27 amRNSHolding(s) in Company
31st Jul 20247:00 amRNSHalf year results 2024
7th Jun 20247:49 amRNSHolding(s) in Company
3rd Jun 20241:17 pmRNSHolding(s) in Company
20th May 20242:03 pmRNSGrant of SAYE Options and PDMR Dealings
16th May 20244:29 pmRNSResult of Annual General Meeting
16th May 20247:00 amRNSTrading Update
12th Apr 20243:48 pmRNSHolding(s) in Company
5th Apr 20243:39 pmRNSDirector/PDMR Shareholding
25th Mar 20248:59 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSFull year 2023 results
18th Jan 20247:00 amRNSTrading Update and Notice of Full Year Results
20th Dec 20237:00 amRNSHolding(s) in Company
18th Dec 202311:38 amRNSDirector/PDMR Shareholding
20th Nov 20234:07 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update, Contract Award and CME
30th Oct 20237:00 amRNSBoard Changes
24th Oct 20233:33 pmRNSHolding(s) in Company
11th Oct 202312:07 pmRNSDirector/PDMR Shareholding
6th Oct 20233:52 pmRNSDirector/PDMR Shareholding
25th Sep 202310:55 amRNSDirector/PDMR Shareholding
22nd Sep 20234:43 pmRNSNotification of Major Holdings
12th Sep 20237:00 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSBoard Changes
16th Aug 20237:00 amRNSInterim CFO Appointment
16th Aug 20237:00 amRNSHalf Year Results 2023
1st Aug 20233:23 pmRNSNotification of Major Holdings
19th Jul 20232:35 pmRNSNotification of Major Holdings
4th Jul 20237:01 amRNSBoard Changes
4th Jul 20237:00 amRNSTrading Update
22nd Jun 20236:08 pmRNSDirector/PDMR, Grant of LTIP
14th Jun 20237:00 amRNSBoard Change
24th May 20234:37 pmRNSNOTIFICATION OF MAJOR HOLDINGS
18th May 20233:42 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.